Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MTRY | Common Stock | Sale | -$3.42K | -570K | -29.8% | $0.01* | 1.34M | Mar 9, 2023 | Direct | F1, F2 |
transaction | MTRY | Common Stock | Other | +75K | +5.59% | 1.42M | Mar 9, 2023 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | This Form 4 is being filed by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). Sandip I. Patel is a manager of NorthStar Co-Sponsor. Accordingly, Mr. Patel has voting and dispositive power over the shares of common stock (the "founder shares") of Monterey Innovation Acquisition Corp. (the "Company") held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. Mr. Patel disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
F2 | In connection with the Company's previously disclosed management transition, and pursuant to share transfer agreements dated March 9, 2023, NorthStar Co-Sponsor transferred (i) 478,125 founder shares to Chardan Monterey Investments LLC and (ii) 30,625 founder shares to each of the Company's three new directors, in each case, at a price of $0.006 per share. |
F3 | On March 9, 2023, Sanjeev Satyal resigned as the Company's Chief Executive Officer and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Co-Sponsor 75,000 of the founder shares that he received from NorthStar Co-Sponsor prior to the Company's initial public offering. |